Peripheral Arterial Disease Trial, Recruiting (NCT07635329)

Peripheral Arterial Disease Trial, Recruiting NCT07635329 Sponsor: Georgetown University Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07635329 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are at least 18 years old.
People who are able to give informed consent and follow the study procedures.
People who have damage to one or both sides of the brain in a specific area, which has caused them to lose part of their vision.
People who are at least three months past a stroke or traumatic brain injury, or who have a brain tumor that has been stable for the past year.
People who are cleared to have an MRI scan based on standard safety checks.

Who may not be able to join:

People who have a serious neurological or mental health condition that is unrelated to their brain injury and that could affect their ability to take part or make the study results harder to interpret.
People who have had a problem with drug or alcohol abuse or addiction in the past six months, as defined by a standard medical classification system called the DSM-5.
People who have a disease or disorder affecting their eyes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2027849920

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07635329

Sponsor: Georgetown University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 2027849920

More information: https://clinicaltrials.gov/study/NCT07635329

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are at least 18 years old.
People who are able to give informed consent and follow the study procedures.
People who have damage to one or both sides of the brain in a specific area, which has caused them to lose part of their vision.
People who are at least three months past a stroke or traumatic brain injury, or who have a brain tumor that has been stable for the past year.
People who are cleared to have an MRI scan based on standard safety checks.

Who may not be able to join:

People who have a serious neurological or mental health condition that is unrelated to their brain injury and that could affect their ability to take part or make the study results harder to interpret.
People who have had a problem with drug or alcohol abuse or addiction in the past six months, as defined by a standard medical classification system called the DSM-5.
People who have a disease or disorder affecting their eyes.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Georgetown University

Registry

ClinicalTrials.gov

Start date

1 July 2026

Est. completion

31 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in high-level perceptual discrimination performance; Change in low-level perceptual discrimination performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov